Shelf life – Page 47

Regulatory Strategy for Stability Data in Post-Approval Changes

Addressing Regulatory Expectations for Stability Data in Post-Approval Changes In today’s dynamic pharmaceutical landscape, managing stability data during post-approval changes poses significant challenges. Failing to meet regulatory expectations for stability…

Photostability Failures in Blister-Packed Products and How to Prevent Them

Addressing Photostability Failures in Blister-Packed Products Photostability failures in blister-packed pharmaceutical products can jeopardize their efficacy and safety, ultimately affecting patient outcomes and compliance with regulatory standards. Such failures often…

Photostability Failures in Blister-Packed Products and How to Prevent Them

Addressing Photostability Failures in Blister-Packed Pharmaceutical Products In the highly regulated pharmaceutical industry, photostability remains a crucial aspect of product integrity and shelf life management. Photostability study failures can significantly…

Stability Study Design Errors in Generic Drug Development

Addressing Errors in Stability Study Design for Generic Drug Development The integrity of stability studies is paramount in generic drug development. Stability study design errors can result in incorrect shelf-life…

Stability Study Design Errors in Generic Drug Development

Overcoming Design Errors in Stability Studies for Generic Drug Development Stability study design errors can significantly impact the regulatory approval process for generic drugs, leading to costly delays and potentially…

How Regulators Evaluate Long-Term and Accelerated Stability Data

Understanding Regulatory Assessments for Stability Studies and Accelerated Data In the pharmaceutical industry, ensuring that products maintain their efficacy and safety throughout their shelf life is paramount. Regulatory authorities are…

How to Justify Protect from Light Label Claims Using Photostability Data

Justifying Light Protection for Label Claims Through Photostability Data In the world of pharmaceutical manufacturing, photostability study failures can pose a significant barrier to compliance and product integrity. Manufacturers must…

Designing Stability Studies Without Creating OOT and OOS Confusion

Addressing Stability Study Design Errors for Reliable Results Stability studies are crucial for ensuring the safety and efficacy of pharmaceutical products throughout their shelf life. Unfortunately, numerous stability study design…

Inspection-Ready Stability Documentation for FDA, EMA and MHRA Audits

Addressing Regulatory Expectations for Stability Studies During Audits In today’s stringent regulatory environment, pharmaceutical companies face ongoing challenges in meeting the regulatory expectations for stability studies as outlined by the…

Photodegradation Risk Assessment for Light-Sensitive Drug Products

Assessing Risks of Photodegradation in Light-Sensitive Pharmaceuticals Photodegradation poses a significant challenge in the pharmaceutical industry, particularly for light-sensitive drug products. It can lead to loss of potency, formation of…

How to Prevent Missing Timepoints in ICH Q1A Stability Studies

Addressing Missing Timepoints in ICH Q1A Stability Studies In the realm of pharmaceutical stability testing, the failure to adhere to pre-defined timepoints can lead to critical data gaps, jeopardizing regulatory…

How to Justify Stability Commitments During Regulatory Review

Establishing Justifications for Stability Commitments in Regulatory Reviews In the field of pharmaceutical manufacturing, understanding and justifying stability commitments during regulatory reviews is crucial for compliance and product quality. Stability…